Moreover, the variance in expression levels of DCPS, EIF4E1B, NUDT1, and NUDT16L1 between glioblastomas (GBMs) and low-grade gliomas (LGGs) suggests their involvement in the progression of glioma malignancy [214]. This evidence concerns the gene NUDT1 and central nervous system cancer.